Key Financial Data Of Reporting Company

Mochida Pharmaceutical Co.,Ltd. - Filing #7300559

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
51,096,000,000 JPY
102,885,000,000 JPY
49,476,000,000 JPY
Ordinary profit (loss)
4,079,000,000 JPY
6,037,000,000 JPY
4,053,000,000 JPY
Net assets
129,106,000,000 JPY
127,967,000,000 JPY
127,305,000,000 JPY
Total assets
158,434,000,000 JPY
158,800,000,000 JPY
156,400,000,000 JPY
Basic earnings (loss) per share
79.71
126.80
78.39
Diluted earnings per share
Equity-to-asset ratio
0.815 xbrli:pure
0.806 xbrli:pure
0.814 xbrli:pure
Net cash provided by (used in) operating activities
8,519,000,000 JPY
-7,480,000,000 JPY
-5,930,000,000 JPY
Net cash provided by (used in) investing activities
9,658,000,000 JPY
74,000,000 JPY
-1,790,000,000 JPY
Net cash provided by (used in) financing activities
-1,432,000,000 JPY
-6,393,000,000 JPY
-4,399,000,000 JPY
Cash and cash equivalents
40,991,000,000 JPY
24,290,000,000 JPY
25,957,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.